Market Overview

Acacia Subsidiary Enters into Settlement Agreement with AstraZeneca

Related ACTG
US Stock Futures Down Ahead Of Industrial Production Data
US Stock Futures Edge Higher; Crude Oil Rises

Acacia Research Corporation (NASDAQ: ACTG) announced today that its
Accuhale LLC subsidiary has entered into a settlement agreement
regarding pressurized metered dose inhalers with AstraZeneca LP (NYSE: AZN),
AstraZeneca Pharmaceuticals LP, AstraZeneca Dunkerque Production SCS and
AstraZeneca AB. The agreement resolves litigation that was pending in
the United States District Court for the Eastern District of Texas.

See full press release

Posted-In: News Guidance Contracts Asset Sales Legal Management Global

 

Related Articles (ACTG + AZN)

Around the Web, We're Loving...

Get Benzinga's Newsletters